Fruquintinib as Maintenance Therapy for Colorectal Cancer Liver Metastasis After Achieving NED: A Phase II Study
A Phase II single-arm prospective study on the clinical efficacy of Fruquintinib as maintenance therapy for colorectal cancer liver metastasis after achieving no evidence of disease (NED).
原文地址: https://www.cveoy.top/t/topic/pqqZ 著作权归作者所有。请勿转载和采集!